These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 891213)

  • 1. Effects of the vasodilating drugs (Diazoxide and Epidrazine) on the central and peripheral circulation.
    Bahlmann J; Brod J; Cachovan M; Dahlgrün H
    Contrib Nephrol; 1977; 8():221-6. PubMed ID: 891213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of peripheral blood circulation values in hypertension following diazoxide administration].
    Bahlmann J; Brod J; Cachovan M; Celsen B; Sippel R
    Verh Dtsch Ges Inn Med; 1975; 81():1049-51. PubMed ID: 1229395
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilator administration in the presence of beta-adrenergic blockade.
    Mroczek WJ; Lee WR; Davidov ME; Finnerty FA
    Circulation; 1976 Jun; 53(6):985-8. PubMed ID: 5209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding and vascular activity of diazoxide.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1969 Nov; 281(21):1141-5. PubMed ID: 5347827
    [No Abstract]   [Full Text] [Related]  

  • 5. Diazoxide--an effective vasodilator in accelerated hypertension.
    Moser M
    Am Heart J; 1974 Jun; 87(6):791-5. PubMed ID: 4828816
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator drugs in the therapy of arterial hypertension].
    Vincentelli GM; Parlapiano C
    Riv Med Aeronaut Spaz; 1979; 42(1-2):161-85. PubMed ID: 400042
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct renal hemodynamic effects of two vasodilators: diazoxide and acetylcholine.
    Chrysant SG; Lavender AR
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):44-56. PubMed ID: 1190913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in heart function during the use of the peripheral vasodilator diazoxide on arterial hypertension patients].
    Shkhvatsabaia IK; Iurenev AP; Klembovskiĭ AA; Dubov PB; Valeev IG
    Kardiologiia; 1985 Mar; 25(3):19-22. PubMed ID: 3999521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasodilators in the treatment of hypertension].
    Huysmans FT; Thien TA
    Ned Tijdschr Geneeskd; 1989 Mar; 133(12):595-9. PubMed ID: 2716872
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of diazoxide on capacitance vessels.
    Bahlmann J; Brod J; Cachovan M
    Eur J Clin Pharmacol; 1978 Jul; 13(5):321-3. PubMed ID: 668792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients].
    Terzoli L; Bianchini C; Cornelli U; Sala C; Leonetti G; Zanchetti A
    Boll Soc Ital Cardiol; 1977; 22(7):1053-6. PubMed ID: 618241
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of epidrazine on renal hemodynamics in hypertensive patients].
    Bianchi C; Bonadio M; Donadio C; Tramonti G; Figus S; Azzollini F
    Boll Soc Ital Cardiol; 1976; 21(8):1287-91. PubMed ID: 1031285
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of diazoxide. (Hyperstat I.V.).
    JAMA; 1973 Jun; 224(10):1422-3. PubMed ID: 4739994
    [No Abstract]   [Full Text] [Related]  

  • 14. Diazoxide in primary pulmonary hypertension.
    Klinke WP; Gilbert JA
    N Engl J Med; 1980 Jan; 302(2):91-2. PubMed ID: 7350437
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of levosimendan on right ventricular function in patients with biventricular heart failure.
    Erdem A; Birhan Yilmaz M
    Crit Care Med; 2010 May; 38(5):1389-90; author reply 1390-1. PubMed ID: 20404640
    [No Abstract]   [Full Text] [Related]  

  • 16. [Continuous intra-arterial pressure recording for 24 hours under basal conditions and during therapy with prizidilol, a vasodilating and beta-blocking drug].
    Fariello R; Alicandri C; Boni E; Montini E; Minniti P; Cinquegrana A; Guarienti P; Zaninelli A; Agabiti-Rosei E; Muiesan G
    Cardiologia; 1983 Feb; 28(2):127-31. PubMed ID: 6142722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients].
    Fariello R; Alicandri C; Agabiti-Rosei E; Romanelli G; Montini E; Muiesan ML; Minniti P; Castellano M; Beschi M; Boni E; Zaninelli A; Micheli P; Platto L; Leto Di Priolo S; Muiesan G
    Boll Soc Ital Cardiol; 1981; 26(11):1871-4. PubMed ID: 6129877
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenolytic and vasodilator therapy.
    McNay JL
    Postgrad Med; 1974 Oct; 56(5):76-80. PubMed ID: 4153271
    [No Abstract]   [Full Text] [Related]  

  • 20. Diazoxide.
    Koch-Weser J
    N Engl J Med; 1976 Jun; 294(23):1271-3. PubMed ID: 772431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.